Drug Shortage Report for FORTAZ
Report ID | 51030 |
Drug Identification Number | 02212226 |
Brand name | FORTAZ - INJ 2G/VIAL |
Common or Proper name | Ceftazidime for injection |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CEFTAZIDIME |
Strength(s) | 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10's |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2018-05-31 |
Estimated end date | |
Actual end date | 2020-12-21 |
Shortage status | Resolved |
Updated date | 2020-12-22 |
Company comments | This product has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2020-12-22 | French | Compare |
v15 | 2020-12-22 | English | Compare |
v14 | 2020-02-27 | French | Compare |
v13 | 2020-02-27 | English | Compare |
v12 | 2019-10-18 | French | Compare |
v11 | 2019-10-18 | English | Compare |
v10 | 2019-07-10 | French | Compare |
v9 | 2019-07-10 | English | Compare |
v8 | 2019-04-10 | French | Compare |
v7 | 2019-04-10 | English | Compare |
v6 | 2018-12-03 | French | Compare |
v5 | 2018-12-03 | English | Compare |
v4 | 2018-06-01 | English | Compare |
v3 | 2018-05-31 | French | Compare |
v2 | 2018-05-31 | English | Compare |
v1 | 2018-05-31 | English | Compare |
Showing 1 to 16 of 16